Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Recent Advances in the Discovery and Development of Novel HIV-1 NNRTI Platforms: 2006-2008 Update

Author(s): Peng Zhan, Xinyong Liu and Zhenyu Li

Volume 16 , Issue 22 , 2009

Page: [2876 - 2889] Pages: 14

DOI: 10.2174/092986709788803231

Price: $65

Abstract

Currently, the long-term usage of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in HIV/AIDS patients eventually leads to the development of drug resistance and severe side effect. Therefore, it is imperative to look for the novel NNRTIs with potent and broad spectrum anti-mutant activity that are also safe and have excellent pharmacokinetic profiles. In this article, newly emerging NNRTIs scaffolds in recent three years, together with the underlying strategies for developing new generation HIV-1 NNRTIs with improved resilience to current drug resistant mutants, are reviewed and analysed.

Keywords: HIV, AIDS, NNRTIs, drug resistance, inhibitor, drug design


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy